Glenmark Logo (Glenmark Logo)
Lithium Carbonate Tablet
Product Images NDC 68462-224
2 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 68462-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label-450-mg-tablet (Label 450 mg Tablet)
The label for Lithium Carbonate Extended-Release Tablets USP, 450 mg, oral tablets, contains 100 tablets per bottle. It is manufactured by Glenmark Pharmaceuticals Limited with Glenmark Pharmaceuticals Inc., USA as the labeler. The label includes dosage, storage instructions, warnings, NDC 68462-224-01, and a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
